Cui Xiangmin's Form 4 filing
CG Oncology, Inc. (CGON) · filed Jan 31, 2024
- Accession no.
- 0001415889-24-002062
- Filed
- Jan 31, 2024, 4:17 PM ET
- Trade date
- Jan 29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market purchases total $7.60M. It was filed 2 days after the trade.
This filing was later replaced by the amendment 0001415889-24-010609 (Apr 9, 2024). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cui XiangminCIK 0001487815 | 10% Owner |
| Decheng Capital Global Life Sciences Fund IV, L.P.CIK 0001834150 | 10% Owner |
| Decheng Capital Management IV (Cayman), LLCCIK 0001843384 | 10% Owner |
| Decheng Capital Global Healthcare Fund (Master), LPCIK 0001949026 | 10% Owner |
| Decheng Capital Global Healthcare GP, LLCCIK 0001949027 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | Common Stock | CConversionAcquired | +3,628,198 | – | – | 4,558,812 | Direct | |
| Jan 29, 2024 | Common Stock | PPurchaseAcquired | +400,000 | $19.00 | +$7,600,000 | 400,000 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2024 | Common Stock | CConversionDisposed | −906,648 | – | – | 0 | Direct | |
| Jan 29, 2024 | Common Stock | CConversionDisposed | −2,259,851 | – | – | 0 | Direct | |
| Jan 29, 2024 | Common Stock | CConversionDisposed | −461,701 | – | – | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.